1. Skip to navigation
  2. Skip to content
  3. Skip to secondary content
  4. Skip to sidebar


gc-banner gc-banner gc-banner gc-banner gc-banner gc-banner gc-banner gc-banner

Scientific Forum

Cancer in Developing Countries: Facing the Challenge

Summaries →

Keynote Speakers and Panellists


A list of keynote speakers and panellists in order of appearance at the 2010 IAEA Scientific Forum is below:

Keynote Speakers

  • Yukiya Amano, IAEA Director General.
  • Dr. Margaret Chan, Director General, World Health Organization (WHO).
  • Mrs. Susanne Mubarak, First Lady of Egypt.
  • Mrs. Khajidsuren Bolormaa, First Lady of Mongolia.
  • Mr Claude Birraux, Special Envoy of French Government.
  • Ms. Mary Ngari, Permanent Secretary of Ministry of Health, Kenya.

Panellists

  • Nik Gowing, Moderator.
  • Dr. Rethy Chhem, IAEA Director, Division of Human Health, Department of Nuclear Sciences and Applications.
  • Dr. Penelope Engel-Hills, Professor of Radiography, Cape Peninsula University, South Africa.

    Penelope Engel-Hills Dr. Penelope Engel-Hills is a Radiation Therapist. She is linked with the Radiation Oncology Department at Groote Schuur Hospital and is a Senior Lecturer at the Cape Peninsula University of Technology, where she is an Associate Professor. Dr. Engel-Hills´ research focus is in work-integrated learning and professional education. Her clinical research is in radiation protection and quality assurance. She has extensive experience in radiation oncology and radiation therapist education on the African continent.


  • Dr. Homer Aquino Macapinlac, Professor, Department of Nuclear Medicine, University of Texas, USA.

    Homer Aquino Macapinlac Dr. Homer Aquino Macapinlac is the James A. Anderson Distinguished Professor of Nuclear Medicine and Chair of the Department of Nuclear Medicine at the University of Texas M.D. Anderson Cancer Center in Houston, Texas. Previously, he served as clinical director at the Memorial Sloan-Kettering Cancer Center in New York. Dr. Macapinlac is board-certified by the American Board of Nuclear Medicine, with a Certificate of Added Qualification in Nuclear Cardiology and is a fellow of the American College of Nuclear Physicians.


  • Dr. Maria do Socorro Maciel, Chief of Breast Department, AC Camargo Hospital, Brazil.

    Maria do Socorro Maciel Dr. Maria do Socorro Maciel is a Breast Surgeon. She graduated from the "Faculdade de Medicina da Universidade de São Paulo" in 1998 and acquired her Ph.D. in 2002. She focuses mainly on breast cancer treatment and factors determining prognosis. She is Chief of the Breast Surgery Department at the AC Camargo Hospital in Sao Paolo, Brazil.


  • Dr. Nancy Read, Professor of Radiation Oncology, University of Western Ontario, Canada.

    Nancy Read Dr. Nancy Read is a Radiation Oncologist who specializes in treating Breast, Head and Neck Cancers. Dr. Read has a strong focus on clinical research and teaching. She is an Associate Professor at the University of Western Ontario and recently won an award for excellence in teaching. Dr. Read also has an interest in patient education and feels strongly that the patient must be an equal partner in making treatment decisions.


  • Dr. Gunilla Svane, Professor of Radiology, Karolinska Institute, Sweden.

    Gunilla Svane Dr. Gunilla Svane is an Associate Professor of Radiology at Karolinska Institutet and Head of the Breast Imaging Section, Department of Radiology, Karolinska University Hospital. Her research has been focused on diagnosis of breast cancer. She developed further the stereotactic technique for needle biopsies of non-palpable breast lesions found by mammography. Much of her research has focussed on the importance of changes in breast density for breast cancer risk.
  • Dr. Puay Hoon Tan, Head, Department of Pathology, Singapore General Hospital.

    Puay Hoon Tan Dr. Puay Hoon Tan is Senior Consultant Histopathologist and Head of the Department of Pathology at Singapore General Hospital. She has an active interest in breast, urologic and renal pathology and sits on several Editorial Boards including Modern Pathology and Breast Cancer Research. She is the recipient of several research grants related to translational studies of breast and prostate cancer. She is the Secretary of the Asian Breast Diseases Association, council member at large of the International Society of Breast Pathology and Councillor for Asia of the International Society of Urological Pathology.


  • Dr. Theodor Vandenberg, Associate Professor, Department of Oncology, University of Western Ontario, Canada.

    Theodor vandenberg Dr. Theodor Vandenberg is Associate Professor of Oncology at the University of Western Ontario. He is London Regional Cancer Program Site Representative for the National Cancer Institute of Canada Clinical Trials Group and is a member of the Board of the Ontario Medical Oncology Associates. Dr. Vandenberg´s research interests include evaluating new treatments for metastatic breast cancer, the treatment of bone metastases, phase II and III trials in breast cancer, neuro imaging studies of "chemo brain", tumour markers and cancer care in the developing world.


  • Dr. Andreas Ullrich, Cancer Control Coordinator, World Health Organisation, Switzerland.

    Andreas Ullrich Dr. Andreas Ullrich is a Medical Officer for Cancer Control at the WHO department of Chronic Diseases and Health Promotion at WHO Headquarters in Geneva. He developed an organization - a wide cancer prevention and control network - which is engaging all relevant technical programmes at WHO Headquarters and Regional Offices. Dr. Ullrich´s current major focus is developing partnerships between WHO and international non-governmental and governmental organizations in cancer control and strengthening links with cancer researchers.


  • Dr. Eduardo Cazap, President Elect, International Union Against Cancer, Argentina.

    Eduardo Cazap Dr. Eduardo Cazap is a medical doctor and the founder and first President of the Latin American and Caribbean Society of Medical Oncology. As of 2010, he is the President of the International Union against Cancer (UICC) in Geneva. In 2009 he was elected Board Member of the American Society of Clinical Oncology, representing the international members. Dr. Cazap has also worked on several collaborative and advisory programs with the World Health Organization and the Pan American Health Organization.


  • Prof. Francesco Cavalli, Member of Board of UICC, Switzerland.

    Franco Cavalli Prof. Franco Cavalli is professor of oncology at the universities of Bern (Switzerland) and Varese (Italy) and Director of the Oncology Institute of Southern Switzerland (IOSI). He is also Chairman of the Scientific Committee of the European School of Oncology. Prof. Cavalli was previously Chairman of the Swiss Group for Cancer Research (SAKK) and founding editor of Annals of Oncology. From 2006 to 2008 he was President of the International Union against Cancer (UICC). Between 1995 and 2007 he was a Member of the Swiss Parliament.


  • Prof. Fabien Calvo, Deputy Director General, Institut National du Cancer (INCa), France.

    Franco Cavalli Prof. Fabien Calvo is Deputy General Director of the National Cancer Institute, France. He is also director of the Cancer Multi-Institutions Alliance in France. He specialised in oncology and haematology. He is currently professor of pharmacology at the Denis Diderot Medical University in Paris. His spheres of interest are the biology of metastatic processes, especially proteases, translational research, preclinical pharmacology and early clinical trials in haematology and oncology.


  • Dr. Craig Nichols, Lance Armstrong Foundation, USA.

    Craig Nichols Dr. Craig Nichols serves as Director of Clinical Program Development and Medical Director of Lymphoma and Testis Cancer Research at Providence Cancer Center. He was formerly Professor of Medicine, the De Armond Chair of Clinical Cancer Research and head of the Division of Hematology and Medical Oncology at Oregon Health and Science University and associate director of the Cancer Institute´s Clinical Research Programme. Dr. Nichols successfully treated seven-time Tour de France winner Lance Armstrong for testicular cancer in 1996 and serves on the Board of Directors for the Lance Armstrong Foundation.


  • Dr. Mark Clanton, Chief Staff Medical Officer, American Cancer Society, USA.

    Mark Clanton Dr. Mark Clanton is chief medical officer of the American Cancer Societies High Plains Division (Texas, Oklahoma, Kansas, Missouri, Nebraska and Hawaii) and deputy chief medical officer for special projects (International Cancer Control and Access to Care in the United States) for the National American Cancer Society in Atlanta, Georgia. He served as deputy director of the United States National Cancer Institute, National Institutes of Health, from 2004 to 2006.


  • Dr. Mohamad Shaalan, Chairman, Breast Cancer Foundation, Egypt.

    Mohamad Shaalan Dr. Mohamad Shaalan is Chairman of the Breast Cancer Foundation of Egypt and Associate Professor of Surgical Oncology at the National Cancer Institute in Cairo. Dr. Shaalan works to spread information and raise awareness, improving early detection and helping women to confront the illness from an informed position so they may consider the best options for their care. Dr. Shaalan is a member of the health committee of Egypt´s ruling party. He is in charge of a national cancer control plan for Egypt.


  • Dr. Paul Ndom, Chairman, Alliance des Ligues et Associations Francophones Africaines et Méditerranéennes (ALIAM), Cameroon.

    Paul Ndom Dr. Paul Ndom heads the Medical Oncology Unit of Yaoundé General Hospital, Cameroon. He is a Lecturer at the Faculty of Medicine and Biomedical Sciences at the University of Yaoundé and founding President of SOCHIMIO, a Non-governmental Organization that is devoted to education, cancer prevention and advocacy. He is also a founder member and the Chairman of "Alliance des Ligues Africaines et Méditéranéennes contre le Cancer (ALIAM)" and Director of the International Network for Cancer Treatment and Research (INCTR) office in Cameroon.


  • Dr. Cary Adams, CEO, International Union Against Cancer, Switzerland.

    Cary Adams Dr. Cary Adams is Chief Executive Officer of the International Union Against Cancer (UICC). He has a degree in Economics, Computing and Statistics from the University of Bath, United Kingdom. Dr. Adams worked with Lloyds TSB Group for many years and was appointed Chief Operating Officer of Lloyds TSB Group International Banking in 2008. After leaving the banking sector, he was appointed Chief Executive Officer of the UICC in September 2009.


  • Dr. Joe Harford, Office of International Affairs, National Cancer Institute, USA.

    Joe Harford Dr. Joe Harford is Director of the Office of International Affairs of the National Cancer Institute. He chairs the Implementation Group of the Ireland-Northern Ireland-NCI Cancer Consortium and is NCI liaison to the Middle East Cancer Consortium, the US-Japan Cooperative Cancer Research Program, the African Organization for Research and Training in Cancer, and the International Network for Cancer Treatment and Research. Dr. Harford is the founding editor of Current Protocols in Cell Biology and Short Protocols in Cell Biology.


  • Dr. Rengaswamy Sankaranarayanan, International Agency for Research on Cancer IARC, France.

    Rengaswamy Sankaranarayanan Dr. Rengaswamy Sankaranarayanan is Head of the Early Detection and Prevention Section and the Screening Group at the International Agency for Research on Cancer (IARC). Dr. Sankaranarayanan has considerable international experience and knowhow in evaluating and disseminating early detection strategies and in providing technical assistance in education and training of cancer early-detection programmes, particularly in low- and medium-resourced countries.


  • Prof. Luiz Antonio Da Silva, General Director, National Cancer Institute, Brazil.

    Luiz Antonio Da Silva Prof. Luiz Antonio Da Silva is General Director of the Brazilian National Cancer Institute. He implemented a pioneer project on the integration of health services with the academic sector. He is an advising editor for the Brazilian Journal of Medical Education and associate professor of the Department of General and Specialized Surgery at the Fluminense Federal University. He helped to implement Brazil´s Unified Health System.


  • Prof. Shamsideen Elgeba, Director-General, Nigerian Nuclear Regulatory Authority, Nigeria.

    Shamsideen Elgeba Prof. Shamsideen Elgeba became the first Director-General of the Nigerian Nuclear Regulatory Authority in 2001. He is concurrently Chairperson of the Forum of Nuclear Regulatory Bodies in Africa (FNRBA) and contributes to the work of the African Union Commission Preparatory Committee for the Conference of State Parties to the African Nuclear Weapons Free Zone Treaty. He has contributed as author and co-author to over 200 scientific publications and technical reports, and has wide experience in energy planning and management, in addition to nuclear safety and security.


  • Dr. Ben Anderson, Chair and Director, Breast Health Global Initiative, USA.

    Ben Anderson Dr. Ben Anderson is Professor of Surgery and Global Health Medicine at the University of Washington in Seattle, where he has devoted his clinical practice to the care of patients with breast cancer and breast health issues. Dr. Anderson holds joint faculty positions in the Fred Hutchinson Cancer Research Center Division of Public Health Sciences and the University of Washington Department Of Global Health. Dr. Anderson created and chairs the Breast Health Global Initiative, the purpose of which is to develop and implement resource-sensitive, culturally appropriate guidelines for breast cancer early detection, diagnosis and treatment in low- and middle-income countries.


  • Prof. Rajendra Achyut Badwe, Director, TATA Memorial Centre, India.

    Rajendra Achyut Badwe Prof. Rajendra Achyut Badwe is Director of the TATA Memorial Centre and Professor and Head of the Department of Surgical Oncology at the Tata Memorial Hospital in India. His specialization is in Breast Cancer Surgery. His research interests include breast cancer, circulating tumour cells, DNA in solid tumours, clinical research methodology, and epidemiological research in oncology. He is a Reviewer for The Lancet, BJC, Cancer, International Journal of Surgery, Annals of Oncology and the Indian Journal of Cancer Surgery. He is an Editorial Board Member of The Breast, the International Journal of Surgery and Mammology.


  • Dr. Rolf Staehelin, Director of International Marketing, Varian Medical Systems, Switzerland.

    Rolf Staehelin Dr. Rolf Staehelin is Director for International Marketing at Varian Medical Systems in Europe, the Middle East, India and Africa. His responsibilities include the introduction of new products and systems as well as clinical research activities. His cooperation with the IAEA´s PACT programme helped to bring about the development of Varian´s UNIQUETM radiotherapy system, which is tailored to cancer treatment needs in developing countries.


  • Dr. Ragnar Dworschak, Director of Technical Services, Best Theratronics Limited, Canada.

    Ragnar Dworschak Dr. Ragnar Dworschak has been Director of Technical Services for Best Theratronics Limited, Canada since January 2010. He works as a technical interface in the Gamma Teletherapy and Cyclotron areas, between the engineering/product development team, sales and marketing and prospective, new and existing client base. He spent the previous five years working as a Reactor Physicist with Atomic Energy of Canada Limited in Chalk River. Dr. Dworschak received a Ph.D. in Laser/Molecular Desorption Physics from the University of Manitoba in Canada.


  • Prof. Mahmoud Mohamed El-Gantiry, National Cancer Institute (NCI), Cairo University, Egypt.

    Mahmoud Mohamed El-Gantiry Prof. Mahmoud Mohamed El-Gantiry is Professor of Radiation Oncology at the National Cancer Institute at Cairo University. He has worked on a number of IAEA research projects and has participated in missions to a number of African countries. He has supervised the IAEA-sponsored fellowships of many radiation oncologists, medical physicists, radiation therapy technologists and nurses in Egypt.


  • Dr. Belal Moftah, Chairman of Biomedical Physics Department, King Faisal Specialist Hospital and Research Centre, Saudi Arabia.

    Belal Moftah Dr. Belal Moftah is Chairman of the Biomedical Physics Department at King Faisal Specialist Hospital and Research Centre in Riyadh. Dr. Moftah served as a clinical radiotherapy physicist and consultant at various institutions. His focus has been on setting up medical physics and radiotherapy services as well as the development of state-of-the-art radiotherapy techniques. He is a counterpart for several IAEA technical cooperation projects as well as Chairman of the IAEA ARASIA Clinical Residency Training Working Group.


  • Dr. Joel Yarney, National Centre for Radiotherapy and Nuclear Medicine, Ghana.

    Joel Yarney Dr. Joel Yarney is Head of the National Centre for Radiotherapy and Nuclear Medicine in Ghana and Director of the treatment facility in Accra. He helped to establish academic training programs in radiation oncology, medical physics and radiation therapy technology in Ghana, which attracts patients and students from across the West African Sub-Region. Among the specialized techniques he has initiated in Ghana is brachytherapy for prostate cancer.


  • Dr. Twalib Ngoma, Department of Radiotherapy and Nuclear Medicine, Ocean Road Hospital, Tanzania.

    Twalib Ngoma Dr. Twalib Ngoma is Executive Director of the Ocean Road Cancer Institute in Tanzania, Director of INCTR Tanzania and Immediate Past President of the African Organization for Research and Training (AORTIC). He is an adviser on cancer control to the Tanzanian Government, WHO and the IAEA. Dr. Ngoma is also the local coordinator of the IAEA Programme of Action for Cancer Therapy Model Demonstration Project in Tanzania and Secretary of the Steering Committee for the development of a National Cancer Control Strategy and Action Plan for Tanzania.


  • Prof. Shengzu Chen, President of Chinese Society of Nuclear Medicine, China.

    Shengzu Chen Prof. Shengzu Chen is Chief Scientist and consultant in the Department of Nuclear Medicine and PET/CT centre of the Cancer Hospital of the Chinese Academy of Medical Sciences and president of the Chinese Society of Nuclear Medicine. Dr. Chen is national coordinator of the IAEA in nuclear medicine. His work has included helping the IAEA to organize a regional training course on sentinel lymph node detection in breast cancer and hosting a regional training course on quality management of positron emission tomography (PET).


  • Dr. Jong-Inn Lee, President, Korea Institute of Radiological & Medical Sciences, South Korea.

    Jong-Inn Lee Dr. Jong-Inn Lee is President of the Korean Institute of Radiological and Medical Sciences (KIRAMS), which has become a regional hub for radiation medicine. As part of its efforts to extend the benefits of radiotherapy to the developing world in collaboration with the IAEA PACT Programme, KIRAMS has trained some 60 medical doctors and scientists from developing countries and dispatched over 20 experts to cancer centers overseas over the last three years. KIRAMS recently launched a project to develop a heavy-ion therapy center and opened a medical branch in Pusan, the second largest city of Korea.


  • Prof. Rajiv Sarin, Director, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), India.

    Rajiv Sarin Prof. Rajiv Sarin is Director of the Advanced Centre for Treatment Research and Education in Cancer (ACTREC) at the Tata Memorial Centre, Mumbai. He is in charge of the Cancer Genetics Unit and Professor of Radiation Oncology at the Tata Memorial Hospital. His research interests include cancer genetics, breast cancer, brain tumours and public health. He has initiated the first comprehensive clinical and laboratory Cancer Genetics Programme in South Asia and heads the ICMR-funded Centre for Advanced Research in Cancer Genetics and Genomics.


  • Dr. Martin Yaffe, Professor, Department of Medical Biophysics, University of Toronto, Canada.

    Martin Yaffe Dr. Martin Yaffe is a Professor in the Department of Medical Biophysics at the University of Toronto and a Senior Scientist. He is Director of the 1mm Cancer Imaging Research Program of the Ontario Institute of Cancer Research, directs the University of Toronto training programme in physics and radiation biology and has led the Physics Consulting Group for The Ontario Breast Screening Program since its inception in 1990. He chairs the IAEA Committee to develop harmonized quality control standards for digital mammography. He is co-author of the book Digital Mammography.


  • Dr. Hiroshi Tsuji, Research Centre for Charged Particle Therapy, NIRS, Japan.

    Hiroshi Tsuji Dr. Hiroshi Tsuji is Group Leader of the Particle Therapy Research Group for developing advanced clinical therapy with charged particles at the NIRS in Japan. He graduated from Hokkaido University School of Medicine. He is primarily involved in clinical research on carbon ion radiotherapy using the heavy ion medical accelerator in Chiba for various kinds of malignant tumors including skull-base tumors, head and neck tumors, lung cancer, liver cancer, pancreatic cancer, prostate cancer, gynaecological cancer, rectal cancer and bone and soft tissue sarcoma.


  • Prof. Niloy Datta, Professor of Radio-oncology, Rajiv Gandhi Cancer Institute and Research Centre, India.

    Niloy Datta Prof. Niloy Datta is Senior Consultant and Co-ordinator, Department of Radiation Oncology at the Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India. His areas of interest include PET CT based radiation treatment planning, image guided teletherapy and brachytherapy, especially in head and neck cancer and breast and cervical cancer. He was also involved in the development of the department of Radiation Oncology at Sanjay Gandhi Postgraduate Institute of Medical Sciences at Lucknow. Prof. Datta is also involved in various IAEA related activities, namely QUARTO programme and PACT mission of the Agency to various countries.


  • Dr. Gunilla Svane, Professor of Radiology, Karolinska Institute, Sweden.

    Gunilla Svane Dr. Gunilla Svane is an Associate Professor of Radiology at Karolinska Institutet and Head of the Breast Imaging Section, Department of Radiology, Karolinska University Hospital. Her research has been focused on diagnosis of breast cancer. She developed further the stereotactic technique for needle biopsies of non-palpable breast lesions found by mammography. Much of her research has focussed on the importance of changes in breast density for breast cancer risk.


  • Dr. Takashi Nakano, National Institute of Radiological Sciences, Japan.

    Takashi Nakano Dr. Takashi Nakano is professor and Chairman of the Radiation Oncology Department and Director of the Heavy Ion Medical Research Center at Gunma University. He is a radiation oncologist who specializes in radiation therapy for gynaecological cancers and charged particle therapy. Dr. Nakano has a strong focus on clinical research and teaching. He contributed to the improvement of the radiation oncology status in Asian countries as the thematic sector lead country coordinator in health sector of IAEA/RCA and as the project lead country coordinator for radiation oncology projects. He is also Chairman of NPO, the Japanese Organization for International Cooperation in Radiation Medicine.


  • Prof. Yoshiharu Yonekura, President, Independent Administrative Institution, National Institute of Radiological Sciences, Japan.

    Yoshiharu Yonekura Prof. Yoshiharu Yonekura is President of the National Institute of Radiological Sciences, Chiba, and Professor Emeritus of the University of Fukui, Japan. After training in Radiology and Nuclear Medicine, he participated in basic and clinical research on positron emission tomography and neuroscience. His current research focuses on molecular imaging for cancer treatment. He has been a member of ICRP Committee 3 since 2005. Prof. Yonekura has been committed to a multitude of national and international activities on scientific research, particularly in radiation protection, for many years.


  • Prof. Pierre Scalliet, Department of Radiation Oncology, St-Luc University Hospital, Belgium.

    Pierre Scalliet Prof. Pierre Scalliet is Chairman of the Radiation Oncology Department at St. Luc University Hospital of the Catholic University of Louvain in Belgium. He has served as Executive Secretary of the European Society for Therapeutic Radiology and Oncology (ESTRO) and is an Editor of the journal Radiotherapy and Oncology. Prof. Scalliet also contributes to the work of the European Organisation for Research and Treatment of Cancer (EORTC). His research interests include high dose rate brachytherapy and quality assurance and safety in radiotherapy. He is currently chairman of the Belgian college of radiotherapy, in charge of developing a safety culture throughout the Belgian radiotherapy community.


  • Prof. Günther Hartmann, German Cancer Research Centre, Germany.

    Gunther Hartmann Prof. Günther Hartmannis Group leader of the Research Group on Dosimetry and Oncological Radiation Physics and Deputy Director of the Department of Medical Physics and Radiation Therapy at the German Cancer Research Centre in Heidelberg. He is an expert in medical physics, with the emphasis on radio-oncology, with many years of experience in implementing new radiation technologies in clinical practice. He is also involved in IAEA activities such as the implementation of medical physics education programs and quality audits.


  • Prof. Carlos Eduardo de Almeida, Chairman, Radiological Sciences Laboratory, State University of Rio de Janeiro (UERJ), Brazil.

    Carlos Eduardo de Almeida Prof. Carlos Eduardo de Almeida is Professor of Medical Physics and Chairman of the Radiological Sciences Laboratory at the University of Rio de Janeiro, Brazil. He received his M.Sc. and PhD at M.D. Anderson Hospital. He is a Fellow of the AAPM and Board Certified by the ACMP. He was previously Director of the Brazilian Radiation Standards Laboratory and Coordinator of the NCI National QA Program in Radiotherapy. He is a medical physicist who has done extensive work on research and training in the radiotherapy physics area and on cost-benefit considerations for cancer care in developing countries.


  • Dr. Gregory Jaczko, Chairman, U.S. Nuclear Regulatory Commission, USA.

    Gregory Jaczko Dr. Gregory Jaczko has been Chairman of the U.S. Nuclear Regulatory Commission since May 2009, having served as a Commissioner since January 2005. Throughout his tenure on the Commission, Dr. Jaczko has focused on the NRC being a decisive safety regulator with the confidence of the public. He has worked to ensure clear communication with the public and with licensees. His professional career has focused on the impact of science in the public policy arena.


  • Prof. Agnes Buzyn, Head, Institut de Radioprotection et de Sûreté Nucléaire, France.

    Agnes Buzyn Prof. Agnes Buzyn is Chairperson of the Board of Directors of the "Institut de Radioprotection et de Sûreté Nucléaire (IRSN)". She is a physician and professor of haematology at Necker Hospital, University Paris Descartes. She leads clinical research projects with many hospitals and universities in the field of leukemia and bone marrow transplantation. Prof. Buzyn patented new tumor markers and biological applications and has published over 100 articles in various scientific publications and medical journals.